Citation Impact

Citing Papers

Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
2012 Standout
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
2007 Standout
Structure of Human Angiotensinogen Gene
1989
Collagen remodeling after myocardial infarction in the rat heart.
1995
Palladium‐Catalyzed Cross‐Coupling Reactions in Total Synthesis
2005 Standout
Arresting a Transient Receptor Potential (TRP) Channel
2010 StandoutNobel
Tissue repair and angiotensin II generated at sites of healing
1997
The Failing Heart — An Engine Out of Fuel
2007 Standout
Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes
2004
CH Bond Functionalization: Emerging Synthetic Tools for Natural Products and Pharmaceuticals
2012 Standout
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Molecular basis of human hypertension: Role of angiotensinogen
1992 Standout
Exercise Standards for Testing and Training
2013 Standout
Vasopeptidase Inhibitors, Neutral Endopeptidase Inhibitors, and Dual Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase
2001
Preservation of Left Ventricular Mechanical Function and Energy Metabolism in Rats After Myocardial Infarction by the Angiotensin-Converting Enzyme Inhibitor Quinapril
1996
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
1990 Standout
Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases
2003
Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction
1995
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes.
1997 StandoutNobel
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Age-associated Cardiovascular Changes in Health: Impact on Cardiovascular Disease in Older Persons
2002
Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart
1997
Infarct scar: a dynamic tissue
2000
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats
2004
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.
1997 StandoutNobel
Catalytic Functionalization of Indoles in a New Dimension
2009 Standout
Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats
1996
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
2000 Standout
The essence of senescence: Figure 1.
2010 Standout
Vascular Smooth Muscle and Endothelial Functions in Aging
2007
Molecular mechanisms of replicative senescence in endothelial cells
2003
Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs
2002
Changes in Gene Expression during Cardiac Growth
1991
Myocardial bioenergetic abnormalities in a canine model of left ventricular dysfunction
1994
Enhanced apoptosis in prolonged cultures of senescent porcine pulmonary artery endothelial cells
2002
Physiology of Local Renin-Angiotensin Systems
2006 Standout
The tissue renin-angiotensin systems in cardiovascular disease
1992
Cardiac fibrosis and inflammation interaction with hemodynamic and hormonal factors
1999
What We Talk About When We Talk About Fat
2014 Standout
Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions
2003
Angiotensin AT receptor contributes to cardiovascular remodelling of aged rats during chronic AT receptor blockade
2004
Recent developments in natural product synthesis using metal-catalysed C–H bond functionalisation
2011 Standout
Angiotensin-converting enzyme and wound healing in diverse tissues of the rat
1996
Renin-angiotensin system in neonatal rats: Induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism
1994
Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction.
1995
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
2007 Standout
Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats
2004
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial
1997
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Aging induces muscle-specific impairment of endothelium-dependent dilation in skeletal muscle feed arteries
2002
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Genetic and Environmental Factors in the Function and Structure of the Arterial Wall
1995
Aberrant Renal Vascular Morphology and Renin Expression in Mutant Mice Lacking Angiotensin-Converting Enzyme
1997 StandoutNobel
Advanced Glycation End Products
2006 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Current Perspectives on Arterial Stiffness and Pulse Pressure in Hypertension and Cardiovascular Diseases
2003 Standout
Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction
1999
Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function
2002
Vasopeptidase Inhibition
2003
Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo
2007 StandoutNobel
Aging and vascular endothelial function in humans
2011
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
2003
BIOLOGICAL FUNCTIONS OF ANGIOTENSIN AND ITS RECEPTORS
1997
Extracellular Matrix Remodeling in Heart Failure
1997
Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
1994
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Impact of Aortic Stiffness on Survival in End-Stage Renal Disease
1999 Standout
Diastereoselective synthesis of mixanpril, an orally active dual inhibitor of neutral endopeptidase and angiotensin converting enzyme
1995
Deletion of p66 shc Gene Protects Against Age-Related Endothelial Dysfunction
2004
Protection of the Arterial Internal Elastic Lamina by Inhibition of the Renin-Angiotensin System in the Rat
1998
Mechanisms of Diabetic Complications
2013 Standout
Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy
1998
Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
1993
Arterial Aging
2005
The Total Synthesis of (+)-Dragmacidin F
2004
Development of an Enantiodivergent Strategy for the Total Synthesis of (+)- and (−)-Dragmacidin F from a Single Enantiomer of Quinic Acid
2005
Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog.
1994
Reserpine:  A Challenge for Total Synthesis of Natural Products
2005
Enhanced Peroxynitrite Formation Is Associated with Vascular Aging
2000
Cellular and Ionic Basis of Arrhythmias in Postinfarction Remodeled Ventricular Myocardium
1996
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Stiffness of Carotid Artery Wall Material and Blood Pressure in Humans
2000
Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats
1996
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
2006 StandoutScience
The infarcted myocardium Simply dead tissue, or a lively target for therapeutic interventions
1999
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
2003 Standout
Crown Ethers:  Sensors for Ions and Molecular Scaffolds for Materials and Biological Models
2004 Standout
Bright, Red Single-Molecule Emitters: Synthesis and Properties of Environmentally Sensitive Dicyanomethylenedihydrofuran (DCDHF) Fluorophores with Bisaromatic Conjugation
2009 StandoutNobel
Creatine and Creatinine Metabolism
2000 Standout
Glucocorticoid antagonists
1987
Molecular phenotyping for analyzing subtle genetic effects in mice: Application to an angiotensinogen gene titration
2002 StandoutNobel

Works of M. Philippe being referenced

Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
1993
Urinary cyclic guanosine monophosphate as an indicator of experimental congestive heart failure in rats
1990
1-N-acylation of gentamicin C1a by a cyclic, chiral .GAMMA.-amino-.ALPHA.-hydroxy acid related to the (S)-4-amino-2-hydroxybutyric acid.
1982
Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries
1994
Effect of Mestranol on Cell Proliferation and Angiotensinogen Production in HepG2 Cells: Relation with the Cell Cycle and Action of Tamoxifen
1987
Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension
1995
Physiological and immunopathological consequences of active immunization of spontaneously hypertensive and normotensive rats against murine renin.
1990
Circulating and cellular markers of endothelial dysfunction with aging in rats
1997
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction.
1988
The influence of various proteases and inhibitors on steroid hormone receptors in rat liver and kidney
1981
Active immunization against renin in normotensive marmoset.
1987
Rankless by CCL
2026